ORIFLAME HOLDING with less fundamental stars is reduced to Neutral

ORIFLAME HOLDING (SE), a company active in the Personal Products industry, loses a star(s) at the fundamental level and sees its general evaluation downgraded. The independent financial analyst theScreener just removed a fundamental star(s) for a 2 over 4-star rating. As such, market behaviour remains unchanged and is evaluated as moderately risky. theScreener believes that the loss of a star(s) merits downgrade to the general evaluation of the title, which passes to Neutral. As of the analysis ...

1 director bought

A director at Oriflame Holdings Ltd bought 75,980 shares at 219.719SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Northern Lights

Oriflame (Hold, TP: SEK347.00) - Low visibility increases Q2 risk

While Q1 revenues were 1% below our estimate, margins were above. Given a weak start to Q2, a more cautious guidance on FX headwinds, a slow season ahead and the lack of growth in three out of four regions, we expect investors to require a discount versus peers going forward. We reiterate our target price of SEK347 while we have upgraded to HOLD (SELL) on valuation.

Northern Lights

Oriflame (Sell, TP: SEK347.00) - Regional and target focus

While we expect focus in the Q1 results to be on the reported figures and growth YTD, we continue to see upside potential on Cetes and growing reliance in Asia & Turkey (results due before market open on 4 May). Short-term we see downside risk due to the announced one-offs and any impact on the long-term growth and margin targets. We reiterate SELL and a SEK347 target price.

Northern Lights

Oriflame (Sell, TP: SEK347.00) - A&T beat, but we remain cautious

Q4 revenues were 4% above our estimate and margins were solidly above our forecast and consensus. We have raised our 2018–2019e adj EPS by c6% and our target price to SEK347 (331); however, we reiterate our SELL recommendation.

Oriflame (Sell, TP: SEK331.00) - Strong growth and margin for A&T

Oriflame reported Q4 revenues and earnings above both our estimates and consensus. On a higher gross margin and with local currency sales up 10% YTD, we expect consensus to move up on the report. The board also suggests an extraordinary dividend of EUR1.00 in addition to an ordinary dividend at EUR1.60.

Northern Lights

Oriflame (Sell, TP: SEK331.00) - Focus on Asia & Turkey

Our Q4 revenue estimate is slightly below consensus, while we are c5% below on adjusted EBIT and c8% below on EPS (results due before market open on 15 February). While we expect focus to be on reported figures and on the pace into 2018, we see upside potential on Cetes and downside risk on Asia & Turkey. Based on our valuation, we have downgraded to SELL (HOLD) and reiterate our target price of SEK331.

Oriflame (Hold, TP: SEK331.00) - Solid pace into Q4

Q3 revenues were 1% below our estimate while margins were above both us and consensus. We have raised our 2017–2019e EPS by c2% after the report. Well into Q4, which is the high season, we expect short-term focus on revenues and medium-term focus on the margin growth outlook for 2018–2019, as well as some slowing price/mix growth. We reiterate our HOLD recommendation but have raised our target price to SEK331 (312).

Sailing into the high season

Our Q3e revenues and EBIT are slightly above consensus, while we are c2% below on EPS (results due before market open on 8 November). Going into the most important season for the company, we see some short-term upside potential. Based on our valuation, we have upgraded the stock to HOLD (SELL) and raised our target price to SEK312 (308).

Sliding into the low season

Oriflame (ORI SS, Sell) - Sliding into the low season (15 pages)

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...